EGRX Earnings History image   This EGRX earnings history page last updated 4/24/2024
EGRX Earnings History Chart
PeriodEarnings DateEarnings
Q2 20238/8/20231.180
Q1 20235/9/20231.260
Q4 20223/13/20231.100
Q3 202211/7/20221.120
Q2 20228/9/20221.560
Q1 20225/9/20224.040
Q4 20213/7/20220.850
Q3 202111/9/20210.560
Q2 20218/9/20210.930
Q1 20215/10/20210.240
Q4 20203/2/20210.960
Q3 202011/2/20201.170
Q2 20208/10/20200.570
Q1 20205/11/20200.840
Q4 20193/2/20200.480
Q3 201911/12/20190.260
Q2 20198/8/20190.840
Q1 20195/7/20191.010
Q4 20182/28/20191.2
Q3 201811/1/20181.18
Q2 20188/7/20180.95
Q1 20185/10/20180.53
Q4 20172/26/20181
Q3 201711/8/20171.22
Q2 20178/9/20170.49
Q1 20175/8/20171.42
Q4 20163/1/20172.69
Q3 201611/9/20160.73
Q2 20168/9/20160.8
Q1 20165/9/2016-0.06
Q4 20152/25/20160.07
Q3 201511/11/2015-0.65
Q2 20158/11/2015-0.53
Q1 20155/12/20151.31
Q4 201412/17/2014-0.91
Q3 20148/11/2014-0.21
Q2 20145/14/2014-0.36
EGRX Revenue History Chart
PeriodEarnings DateRevenue
Q2 20238/8/20230.06B
Q1 20235/9/20230.07B
Q4 20223/13/20230.06B
Q3 202211/7/20220.07B
Q2 20228/9/20220.07B
Q1 20225/9/20220.12B
Q4 20213/7/20220.04B
Q3 202111/9/20210.04B
Q2 20218/9/20210.05B
Q1 20215/10/20210.04B
Q4 20203/2/20210.05B
Q3 202011/2/20200.05B
Q2 20208/10/20200.04B
Q1 20205/11/20200.05B
Q4 20193/2/20200.05B
Q3 201911/12/20190.04B
Q2 20198/8/20190.06B
Q1 20195/7/20190.05B
Q4 20182/28/201956.05M
Q3 201811/1/201851.34M
Q2 20188/7/201859.30M
Q1 20185/10/201846.63M
Q4 20172/26/201846.78M
Q3 201711/8/201763.02M
Q2 20178/9/201750.11M
Q1 20175/8/201776.79M
Q4 20163/1/201781.14M
Q3 201611/9/201637.83M
Q2 20168/9/201640.92M
Q1 20165/9/201629.59M
Q4 20152/25/201618.18M
Q3 201511/11/20155.74M
Q2 20158/11/20156.00M
Q1 20155/12/201536.31M
Q4 201412/17/20142.88M
Q3 20148/11/20145.80M
Q2 20145/14/20143.22M
Quotes delayed 20 minutes

Email EnvelopeFree EGRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options

Next Earnings Date Calendar:

Vertiv Hldgs (VRT): 4/24/2024 5:00 AM
Lithia Motors (LAD): 4/24/2024 5:00 AM
Central Pacific Financial (CPF): 4/24/2024 5:30 AM
Thermo Fisher Scientific (TMO): 4/24/2024 6:00 AM
Hilton Worldwide Holdings (HLT): 4/24/2024 6:00 AM
TE Connectivity (TEL): 4/24/2024 6:00 AM
Synchrony Finl (SYF): 4/24/2024 6:00 AM
Bunge (BG): 4/24/2024 6:00 AM
Owens-Corning (OC): 4/24/2024 6:00 AM
Pacific Premier Bancorp (PPBI): 4/24/2024 6:00 AM

More from the Next Earnings Dates Calendar

Earnings History:

Rush Enterprises (RUSHA): 4/23/2024 6:01 PM
Rush Enterprises (RUSHB): 4/23/2024 6:01 PM
Molecular Templates (MTEM): 4/23/2024 6:00 PM
Flushing Financial (FFIC): 4/23/2024 5:29 PM
First Busey (BUSE): 4/23/2024 5:00 PM
Encore Wire (WIRE): 4/23/2024 5:00 PM
Baker Hughes (BKR): 4/23/2024 5:00 PM
Enterprise Bancorp (EBTC): 4/23/2024 After close
Range Resources (RRC): 4/23/2024 After close
Veritex Holdings (VBTX): 4/23/2024 After close

More from the Earnings History archive
Eagle Pharmaceuticals (EGRX) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

EHAB Past Earnings
EHC Past Earnings
EIGR Past Earnings
EKSO Past Earnings
ELAN Past Earnings
ELDN Past Earnings
ELEV Past Earnings
ELOX Past Earnings
ELUT Past Earnings
ELVN Past Earnings
On this page we presented the EGRX earnings and revenue history archive for Eagle Pharmaceuticals, comparing the historical top line revenue performance quarter by quarter, as well as the EGRX earnings per share history. Any self directed investor doing their due diligence on EGRX (or any other given stock) can benefit from researching all of the Eagle Pharmaceuticals past earnings and revenue results going backwards in time, and to help you with this Eagle Pharmaceuticals earnings history research, on this page we presented each quarter's resulting numbers in both table and graphical form for easy comparison. Studying these numbers can help an investor by providing important context with which to think about EGRX's next earnings report. In your continued research on Eagle Pharmaceuticals we hope you will be sure to check out the further links included for earnings surprises as well as next earnings dates for EGRX. Thanks for visiting, and the next time you need to research EGRX earnings history (or the earnings history of another stock), we hope you'll think of our site as your go-to earnings history research resource of choice.

Recommended: ZBH DMA, ATS Options Chain, Institutional Holders of SPCM.

 

EGRX Earnings History | www.NextEarningsDate.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in NextEarningsDate.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.